We are live on ! Find out more
SI

Sofinnova Investments Portfolio holdings

AUM $2.63B
1-Year Est. Return 117.41%
This Fund
S&P 500
This Quarter Est. Return
+35.61%
1 Year Est. Return
+117.41%
3 Year Est. Return
+428.82%
5 Year Est. Return
+748.21%
10 Year Est. Return
–
AUM
$582M
AUM Growth
–
Cap. Flow
+$600M
Cap. Flow %
103.21%
Top 10 Hldgs %
91.48%
Holding
54
New
54
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$139M
2
NCNA
NuCana
NCNA
+$88.6M
3
OBSV
ObsEva SA Ordinary Shares
OBSV
+$58.3M
4
BOLD
Audentes Therapeutics, Inc
BOLD
+$46.7M
5
PDSB icon
PDS Biotechnology
PDSB
+$38.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDNY
51
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$155K 0.03%
+3,339
New +$122K
CALA
52
DELISTED
Calithera Biosciences, Inc
CALA
$126K 0.02%
+996
New +$155K
ONCS
53
DELISTED
OncoSec Medical Incorporated
ONCS
$126K 0.02%
+304
New +$125K
CDTX
54
DELISTED
Cidara Therapeutics
CDTX
$52K 0.01%
+648
New +$88.5K
1 2
3

Similar funds

WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
NIG
NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Sofinnova Investments's Q1 2018 Portfolio in Review

Q1 2018 is the first quarter with a 13F filing on record for Sofinnova Investments, which disclosed 54 positions worth $582M. Its ten largest holdings account for 91% of the portfolio.

Its largest position is Ascendis Pharma A/S: 2,479,514 shares worth $162M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets.

  • Sofinnova Investments's largest Q1 2018 buy was Ascendis Pharma A/S: 2,479,514 shares worth $162M.
  • Sofinnova Investments's ten largest holdings make up 91% of its $582M portfolio in Q1 2018.
  • Sofinnova Investments disclosed 54 positions in Q1 2018, its first 13F filing on record.

Based on Sofinnova Investments's 13F filing for Q1 2018, filed 15 May 2018.